New vaccine panel members as RFK reshapes CDC oversight

16 September 2025

The US Department of Health and Human Services (HHS) has appointed five new members to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP). The move, announced September 15, reflects health secretary Robert F Kennedy Jr’s broader effort to overhaul the panel, which plays a central role in shaping national vaccination policy.

Mr Kennedy, who reconstituted ACIP in June, said the changes were aimed at improving transparency and public trust. The committee’s new appointees include Catherine Stein, professor of epidemiology at Case Western Reserve University; Evelyn Griffin, an obstetrician-gynecologist in Louisiana; Hillary Blackburn, a pharmacy leader with AscensionRx; Kirk Milhoan, a pediatric cardiologist and clinic director in Hawaii; and Raymond Pollak, a transplant specialist with extensive research and leadership credentials.

Shifting tone in vaccine policy

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight



More Features in Pharmaceutical